Renewable Energy Insights > Troutman Sanders LLP

Category — Tobacco Products

TMA Hosts Conference on Deeming Regulations

Earlier this week, the Tobacco Merchants Association hosted a conference on the FDA’s proposed tobacco product deeming regulations, which would subject a host of new products — including e-cigarettes, cigars and pipe tobacco — to the FDA’s regulatory authority.  The Troutman Sanders tobacco team participated in the discussion regarding how the industry can best contribute to the ongoing debate as to how these products should be regulated, if at all. [Read more →]

June 19, 2014   Comments Off

Troutman Sanders Tobacco Team Quoted in Article Regarding Domestic E-Cigarette Production

Troutman Sanders tobacco team partner Bryan Haynes was quoted in a May 25th Reuters article titled “Quality issues push e-cigarette production to U.S. from China.” [Read more →]

May 27, 2014   Comments Off

E-Cigarette Tax Bill Clears North Carolina House

A bill that would tax e-cigarettes as “vapor products” has cleared the North Carolina House of Representatives.  The bill is now pending in the Senate. [Read more →]

May 27, 2014   Comments Off

Should Vapers be Subject to Higher Insurance Premiums Applicable to “Smokers” and “Tobacco Users”?

Under the Patient Protection and Affordable Care Act (the “Affordable Care Act”) (also known as “ObamaCare”), which became law in 2010, health insurance companies may charge smokers and tobacco users more than those who do not smoke or use tobacco.  Specifically, smokers and tobacco users may be charged up to 50 percent more. [Read more →]

May 27, 2014   Comments Off

Maryland Attorney General Questions E-Cigarette Companies

Last week, Maryland Attorney General Douglas Gansler wrote to ten e-cigarette companies raising issues regarding potential nicotine poisoning and purported marketing to minors. [Read more →]

May 10, 2014   Comments Off

Testing E-Cigarettes

The FDA’s proposed deeming regulations call for testing of harmful and potentially harmful constituents in electronic cigarettes.  Those requirements would not be triggered until three years after the regulations become effective, and in the meantime the FDA presumably would need to establish protocols for e-cigarette testing and a list of constituents to be reported. [Read more →]

May 10, 2014   Comments Off

Troutman Sanders Tobacco Practice Publishes Article in Smokeshop Magazine on Litigation Over E-Cigarette Marketing

An article by the Troutman Sanders tobacco practice appears in the April issue of Smokeshop Magazine. The article, titled “E-Cigarette Marketing: Misleading or Puffery?,” discusses lawsuits filed by plaintiff’s attorneys against e-cigarette companies regarding their marketing practices.  The full text of the article can be found here.

For questions and/or comments, please contact Bryan Haynes, at 804.697.1420 or by email.

 

May 10, 2014   Comments Off

Troutman Sanders Tobacco Practice Quoted on FDA Deeming Regulations

The Troutman Sanders tobacco practice has been quoted in two recent articles regarding the FDA’s recent move to extend regulatory oversight to e-cigarettes, cigars, pipe tobacco and other tobacco products.  [Read more →]

April 25, 2014   Comments Off

The FDA’s New Deeming Regulations — Get Your Comments In!

The FDA issued proposed regulations yesterday that would extend the FDA’s regulatory authority under the Tobacco Control Act to all tobacco products, including e-cigarettes, cigars and pipe tobacco.  It is important to note that this is a proposal only, and the regulations could become more reasonable or more onerous after a public comment period. [Read more →]

April 25, 2014   Comments Off

The FDA’s New Deeming Regulations– Preliminary Observations — Electronic Cigarettes

FDA’s proposed deeming regulation issued earlier today would cover a variety of products that meet the statutory definition of a “tobacco product,” including electronic cigarettes, cigars and pipe tobacco.  This blog entry discusses three provisions that would apply to the tobacco products “deemed” to be subject to FDA regulation.  [Read more →]

April 24, 2014   Comments Off